One clearer read
at the start.

See beyond binding

A simple, fast ~16h workflow designed to reduce uncertainty at the first decision point in your clinical pipeline.

We have designed the MHC-SNAP technology to rapidly identify peptide ligands that bind and stabilise the MHC class I protein complex.

2025 Asia Bio Startup Spotlight Finalist

2025 Amgen Golden Ticket Finalist

In the spotlight

2022 1st runner up in ShanghaiTech Innovation and Entrepreneurship Summit

Otter Bio

Company

© 2026 by Otter Bio Pte Ltd. All Rights Reserved.

Discovering T cell epitope leads that endure via fragmentable MHC class I proteins

Work with us